Immunocore Holdings plc (IMCR) Asserts Pipeline Development and Strong Commercial Performance

Immunocore Holdings PLC (NASDAQ:IMCR) is one of the best 52-week high stocks to buy right now. Immunocore Holdings PLC (NASDAQ:IMCR) commands a consensus Moderate Buy rating from 9 Wall Street analysts, comprising 6 Buy and 3 Hold ratings. The average price target on the stock is $65.25, implying 62.25% upside potential.

On November 21, H.C. Wainwright’s Patrick Trucchio reaffirmed a Buy rating on Immunocore Holdings with a $100 price target, following TD Cowen’s Tyler Van Buren, who also issued a Buy on November 13.

Just days earlier, on November 19 at the Jefferies London Healthcare Conference 2025, Immunocore Holdings showcased strategic advancements that affirmed significant pipeline development and strong commercial performance. It has made significant progress on KIMMTRAK development, currently in Phase 3 trials in cutaneous melanoma.

The company is working on PRAME Bispecific, currently in Phase 3 trials as a potential treatment option for multiple cancers, with data expected in the first half of next year. In addition, it is pursuing cures for HIV and HBV. The pipeline development is supported by a robust cash position of about $892 million as of the end of the third quarter.

Immunocore Holdings plc (NASDAQ:IMCR) is a biotechnology company that develops TCR bispecific immunotherapies to treat cancer, infectious diseases, and autoimmune conditions. Using its proprietary ImmTAX technology, the company designs therapies that harness the immune system by either activating it to destroy diseased cells or dampening it to reduce autoimmune responses.

While we acknowledge the potential of IMCR as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: Top 10 Materials Stocks to Buy According to Analysts and 10 Best Organic Food and Farming Stocks to Buy Now.

Disclosure: None. This article is originally published at Insider Monkey.